[PSTX] QoQ Quarter Result on 30-Sep-2021 [#Q3]

Stock
[PSTX] Poseida Therapeutics, Inc.
Announcement Date
09-Nov-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q3]
Profit Trend
QoQ- 7.18%
YoY- -23.28%
Quarter Report
PSTX's Result
PSTX's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 2,700 1,435 31 0 0 0 0 -
PBT -43,036 -58,057 1 -42,424 -45,705 -38,314 -36 11310.97%
Tax 1,491 1,096 -17,602 840 860 826 -1,039 -
NP -44,527 -59,153 1 -42,424 -45,705 -38,314 -36 11573.76%
Tax Rate - - 1,198,216.25% - - - - -
Total Cost 47,227 60,588 30 42,424 45,705 38,314 36 12042.33%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin -1,649.15 -4,122.16 4.70 0.00 0.00 0.00 0.00 -
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
EPS -0.71 -0.95 0.02 -0.68 -0.74 -0.62 -0.00 -
EPS Diluted -0.71 -0.95 0.02 -0.68 -0.74 -0.62 -0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.